Search research articles
Contact Us
Filters
Showing results (61-70 of 225) with videos related to
Page
of 23
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis
|
May 10, 2021
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
Jan Beyer-Westendorf, Sandra Marten, Luise Tittl, et al.
Thrombosis Journal
|
October 8, 2024
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing
Lars Heubner, Oliver Grottke, Oliver Vicent, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery
|
October 31, 2006
Influence of Cyclosporin A on human gingival keratinocytes in vitro
Günter Lauer, Ronald Mai, Winnie Pradel, et al.
Thrombosis and Haemostasis
|
February 27, 2016
Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy
Jan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
European Journal of Haematology
|
October 18, 2018
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism
Christine G Kohn, Thomas J Bunz, Jan Beyer-Westendorf, et al.
Journal of Vascular Surgery
|
July 16, 2010
Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study
Thomas Schwarz, Lutz Buschmann, Jan Beyer, et al.
Thrombosis Research
|
June 9, 2018
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study
Craig I Coleman, W Frank Peacock, Thomas J Bunz, et al.
The Lancet. Haematology
|
October 4, 2016
Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series
Jan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Scientific Reports
|
October 25, 2023
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Stephan Baldus, Jan Beyer-Westendorf, Helge Möllmann, et al.
Journal of Thrombosis and Thrombolysis
|
June 9, 2018
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Page
of 23
Search research articles
Search
Showing results (61-70 of 225) with videos related to
Sort By:
Page
of 23
TH Open : Companion Journal to Thrombosis and Haemostasis
|
May 10, 2021
Venous Thromboembolism Therapy with Apixaban in Daily Care Patients: Results from the Dresden NOAC Registry
Jan Beyer-Westendorf, Sandra Marten, Luise Tittl, et al.
Thrombosis Journal
|
October 8, 2024
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing
Lars Heubner, Oliver Grottke, Oliver Vicent, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery
|
October 31, 2006
Influence of Cyclosporin A on human gingival keratinocytes in vitro
Günter Lauer, Ronald Mai, Winnie Pradel, et al.
Thrombosis and Haemostasis
|
February 27, 2016
Vaginal bleeding and heavy menstrual bleeding during direct oral anti-Xa inhibitor therapy
Jan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
European Journal of Haematology
|
October 18, 2018
Comparative risk of major bleeding with rivaroxaban and warfarin: Population-based cohort study of unprovoked venous thromboembolism
Christine G Kohn, Thomas J Bunz, Jan Beyer-Westendorf, et al.
Journal of Vascular Surgery
|
July 16, 2010
Therapy of isolated calf muscle vein thrombosis: a randomized, controlled study
Thomas Schwarz, Lutz Buschmann, Jan Beyer, et al.
Thrombosis Research
|
June 9, 2018
Effectiveness and safety of rivaroxaban versus warfarin in patients with unprovoked venous thromboembolism: A propensity-score weighted administrative claims cohort study
Craig I Coleman, W Frank Peacock, Thomas J Bunz, et al.
The Lancet. Haematology
|
October 4, 2016
Management and outcomes of vaginal bleeding and heavy menstrual bleeding in women of reproductive age on direct oral anti-factor Xa inhibitor therapy: a case series
Jan Beyer-Westendorf, Franziska Michalski, Luise Tittl, et al.
Scientific Reports
|
October 25, 2023
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
Stephan Baldus, Jan Beyer-Westendorf, Helge Möllmann, et al.
Journal of Thrombosis and Thrombolysis
|
June 9, 2018
Effectiveness and safety of rivaroxaban versus warfarin in patients with provoked venous thromboembolism
Craig I Coleman, Alexander G G Turpie, Thomas J Bunz, et al.
Page
of 23